Lecanemab-Irmb Injection

51 interactions 14 cited references
Also sold as: Leqembi Leqembi®
About Lecanemab-Irmb Injection

Lecanemab-irmb injection is used to treat Alzheimer's disease (a brain disorder that affects the ability to remember, think clearly, communicate, and perform daily activities and may cause changes in mood and personality) in patients with mild disease. Lecanemab-irmb is in a class of medications called monoclonal antib… Read the full Lecanemab-Irmb Injection drug information page →

Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Aug 10, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Major

Lecanemab-Irmb Injection Acenocoumarol An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details Lecanemab-Irmb Injection Alteplase, Recombinant Activase An increased risk of amyloid related imaging abnormalities or intracerebral hemorrhage Details Lecanemab-Irmb Injection Anistreplase An increased risk of amyloid related imaging abnormalities or intracerebral hemorrhage Details Lecanemab-Irmb Injection Apixaban Eliquis An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details Lecanemab-Irmb Injection Ardeparin An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details Lecanemab-Irmb Injection Argatroban An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details Lecanemab-Irmb Injection Bemiparin An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details Lecanemab-Irmb Injection Betrixaban Bevyxxa® An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details Lecanemab-Irmb Injection Bivalirudin Angiomax An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details Lecanemab-Irmb Injection Certoparin An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details Lecanemab-Irmb Injection Dabigatran Etexilate An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details Lecanemab-Irmb Injection Dalteparin Fragmin An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details Lecanemab-Irmb Injection Danaparoid An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details Lecanemab-Irmb Injection Desirudin Iprivask An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details Lecanemab-Irmb Injection Edoxaban Savaysa An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details Lecanemab-Irmb Injection Enoxaparin Lovenox An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details Lecanemab-Irmb Injection Fondaparinux Arixtra An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details Lecanemab-Irmb Injection Heparin An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details Lecanemab-Irmb Injection Lepirudin An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details Lecanemab-Irmb Injection Nadroparin An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details Lecanemab-Irmb Injection Parnaparin An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details Lecanemab-Irmb Injection Phenindione An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details Lecanemab-Irmb Injection Phenprocoumon An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details Lecanemab-Irmb Injection Protein C Ceprotin An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details Lecanemab-Irmb Injection Reteplase, Recombinant An increased risk of amyloid related imaging abnormalities or intracerebral hemorrhage Details Lecanemab-Irmb Injection Reviparin An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details Lecanemab-Irmb Injection Rivaroxaban Xarelto An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details Lecanemab-Irmb Injection Streptokinase An increased risk of amyloid related imaging abnormalities or intracerebral hemorrhage Details Lecanemab-Irmb Injection Sulodexide An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details Lecanemab-Irmb Injection Tenecteplase An increased risk of amyloid related imaging abnormalities or intracerebral hemorrhage Details Lecanemab-Irmb Injection Tinzaparin An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details Lecanemab-Irmb Injection Urokinase An increased risk of amyloid related imaging abnormalities or intracerebral hemorrhage Details Lecanemab-Irmb Injection Warfarin Coumadin An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.